Pfizer and Lilly Announce Top-Line Results From Second Phase 3 Study of Tanezumab in Osteoarthritis Pain Read more
Eureka Therapeutics Announces FDA Clearance of IND Application for Phase 1/2 Trial of ET140202 Artemis T-Cell Therapy Read more
Genentech to Discontinue Phase III CREAD 1 and 2 Clinical Studies of Crenezumab in Early Alzheimer’s Disease (AD) Read more